Angela Higgins

Title: Angela Higgins: Innovator in HDL Purification and Detection

Introduction

Angela Higgins is a prominent inventor based in Beachwood, Ohio. She has made significant contributions to the field of biochemistry, particularly in the purification and detection of high-density lipoprotein (HDL) and apolipoprotein A1 (ApoA1). With a total of three patents to her name, Higgins is recognized for her innovative approaches to health diagnostics.

Latest Patents

Higgins' latest patents focus on compositions and methods for the purification and detection of HDL and ApoA1. The inventions provide methods, kits, and compositions for purifying HDL molecules from samples, such as blood, using HDL tagging molecules that include an HDL lipophilic core binding peptide and an affinity tag. Additionally, her patents detail methods for detecting non-fragmented ApoA1 using mass spectrometry. These advancements allow for the tagging of HDL molecules in a sample with detectably labeled ApoA1 molecules, enabling the determination of the ratio of labeled ApoA1 to native ApoA1 proteins.

Career Highlights

Angela Higgins is currently employed at Cleveland HeartLab, Inc., where she continues to develop her innovative ideas. Her work has been instrumental in advancing the understanding of HDL and its role in cardiovascular health.

Collaborations

Higgins collaborates with notable colleagues, including Timothy Collier and Cory E. Bystrom, who contribute to her research and development efforts.

Conclusion

Angela Higgins stands out as a leading inventor in the field of HDL purification and detection. Her contributions are paving the way for advancements in health diagnostics and improving patient outcomes.